0001429386-15-000001.txt : 20151229 0001429386-15-000001.hdr.sgml : 20151229 20151229113223 ACCESSION NUMBER: 0001429386-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151229 DATE AS OF CHANGE: 20151229 EFFECTIVENESS DATE: 20151229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHASERX, INC. CENTRAL INDEX KEY: 0001429386 IRS NUMBER: 204690620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254009 FILM NUMBER: 151310627 BUSINESS ADDRESS: STREET 1: 410 WEST HARRISON STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-805-6300 MAIL ADDRESS: STREET 1: 410 WEST HARRISON STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: PHASERX INC DATE OF NAME CHANGE: 20080311 D 1 primary_doc.xml X0707 D LIVE 0001429386 PHASERX, INC. 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 206-805-6300 DELAWARE PHASERX INC Corporation true ROBERT W. OVERELL 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer Director Promoter Michael Houston 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer BRIAN ATWOOD 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK CA CALIFORNIA 94025 Director Richard Ulevitch 2200 SAND HILL ROAD SUITE 110 MENLO PARK CA CALIFORNIA 94025 Director STEVEN GILLIS 8725 WEST HIGGINS ROAD SUITE 290 CHICAGO IL ILLINOIS 60631 Director PAUL JOHNSON 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Executive Officer Director JOHN SCHMIDT 410 WEST HARRISON STREET SUITE 300 SEATTLE WA WASHINGTON 98119 Director Biotechnology Decline to Disclose 06b false 2015-12-21 false true true true false 0 Palladium Capital Advisors, LLC 129400 None None 230 Park Avenue Suite 539 New York NY NEW YORK 10169 NJ NEW JERSEY NY NEW YORK ID IDAHO CA CALIFORNIA FL FLORIDA true 4000000 4000000 0 false 17 280000 true 0 Palladium Capital Advisors, LLC?s commission calculation is based on the combination of a cash fee and a non-accountable expense allowance. 0 false PHASERX, INC. /s/ Robert W.Overll Robert W.Overll PRESIDENT AND CHIEF EXECUTIVE OFFICER 2015-12-29